View all veterinary jobs
VetSurgeon.org publishes a curated feed of veterinary news for practising veterinary surgeons, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest, or professional significance — filtering out noise so busy vets can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, farm, equine and exotic species.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetSurgeon News by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
Novartis Animal Health has launched Helping Hearts, a competition in which veterinary surgeons have the chance to brush up on their cardiology whilst at the same time triggering a donation to Hounds for Heroes and entering the running to win one of 10 Red Letter Day experiences.
To enter the competition, visit www.notjustoneheart.com.
Each entry triggers a donation of £1 to Hounds for Heroes, a charity which provides specially trained assistance dogs to injured and disabled men and women of both the UK Armed Forces and Civilian Emergency Services.
Hounds for Heroes was set up by Allen Parton, who was himself injured in service. Allen freely admits that he owes his life to Endal - a Labrador that developed skills beyond his initial basic training and who proved so inspiring to everyone who met him and that he was awarded the accolade 'Dog of the Millennium'. With three squadrons of puppies currently in basic training, there are hopefully a few more canine heroes like Endal waiting in the wings.
Senior Category Manager Cardiology/Nephrology Brock Abreu said: "Here at Novartis Animal Health, we are absolutely thrilled to be supporting such a life-changing and life-enhancing cause. I know this is a charity that many vets feel they can relate to and we are encouraging as many of them as possible to take part. I'd be delighted if we were inundated with entries and could make an impressive donation to Hounds for Heroes on behalf of vets across the country."
The competition is open till 31st December 2013.
The RCVS Disciplinary Committee has agreed to accept undertakings from a Dorset veterinary surgeon, Philippa Ann Rodale MBE, in which she requests that her name is removed from the RCVS Register of Veterinary Surgeons with effect from 31 July 2015, and undertakes never to apply to be restored to it.
The Committee met on Monday 17 August, resuming a hearing which had been adjourned on 20 July. The adjournment had been made to allow Ms Rodale time to submit formal responses to the charges against her and indicate whether she agreed with them. In the event, as outlined by a letter from her solicitors received by the College on 14 August, Ms Rodale declined to comment on the charges and did not admit to any of them.
Ms Rodale did not attend the hearing on 17 August, however, the Committee decided to continue in her absence, on the understanding that, as evidenced by her solicitors’ letter, she was fully aware of the hearing and had voluntarily waived her right to be presented and represented.
The original charges related to Ms Rodale’s standards of practice (in relation to issues such as biosecurity, hygiene, in-patient facilities, drug storage and the disposal of hazardous waste, among other things) and also to a test for Intradermal Comparative Tuberculin. The charges relating to her standards of practice did not have complainants, as the College raised the matters itself; with respect to the Tuberculin test charge, the Animal and Plant Health Agency, as the relevant body, raised no objection to the proposed course of accepting undertakings.
In accepting the undertakings, the Committee felt that a contested hearing that could take up to seven days and involve up to eight witnesses for the College and up to three for the Respondent would not be in the public interest. Furthermore, since the 20 July hearing, Ms Rodale had retired and closed her practice. The Committee also noted that there had been no previous disciplinary findings against her, in what was otherwise a long and unblemished career.
Ian Green, chairing the Committee and speaking on its behalf, said: “The Committee is satisfied that the undertakings offered by the Respondent protect the welfare of animals since the Respondent has now retired and is no longer in practice. It is also satisfied that the reputation of the profession is upheld since the undertakings offered go beyond any sanction which the Committee could impose at the conclusion of a contested hearing, were any of the Heads of Charge to be found proved. It considers that it would not be proportionate or in the public interest for there to be a lengthy contested hearing.”
Extensively updated, the new edition reflects the increasing sophistication of reptile medicine and surgery and acknowledges the expanding range of reptile species kept as companion animals.
Part one covers the husbandry aspects of reptile care, including captive maintenance and nutrition, plus a new chapter dedicated to anatomy and physiology.
Part two contains the details necessary to carry out successful clinical examination, anaesthesia, surgery (including endoscopy), treatment (including emergency and critical care), non-invasive imaging, laboratory testing and post-mortem examinations, as well as humane euthanasia.
Part three addresses disease by organ system, covering parasitology and infectious disease.
New to this third edition are also chapters on marine turtle rehabilitation and crocodilians, as well as updates on the handling of venomous reptiles.
Simon Girling said: "This third edition of the BSAVA Manual of Reptiles is another milestone in the commitment of the BSAVA to exotic species medicine. Reptile medicine and surgery is now being accepted as a mainstream discipline within the veterinary world, reflected in the growing number of textbooks and the appearance of postgraduate qualifications."
BSAVA says the new manual will benefit both the general practitioner seeing a small number of reptiles or a more specialist practitioner dealing with these species on a daily basis.
BVA President Gudrun Ravetz said: "Veterinary View not only highlights some of the veterinary profession's fantastic work, but complements our joint project with RCVS, Vet Futures, in exploring how the profession can best shape its own future. We hope it will stimulate debate among vets, and the wider community in which we work, about both the big challenges and opportunities that the veterinary profession is facing."
The series includes a number of videos which showcase more recent industry developments:
Stem Cell therapy for the treatment of canine osteoarthritis (VetCell Therapeutics)
Pharmtrax, a mobile device for vets to record work and dispensing on the farm (Henry Schein Animal Health)
Hormone implants as an alternative to castration (Virbac Animal Health)
Practice management support from Zoetis
Preventing an epidemic of equine flu (Merial Animal Health)
On top of that, over 25% of vets said they don't talk to their farmer clients about the disposal of empty pharmaceutical waste.
The survey also found that while veterinary surgeons are aware that both glass and shatterproof plastic vials are incinerated, over 65% of those questioned believed that glass vials were more environmentally friendly, when in fact, the company says its CLAS (Ceva Layered Anti Shatter) shatterproof plastic vials have 33% less impact on the environment from cradle to grave2.
Ceva is producing a range of support materials, including tailored social media and newsletter content, to help vets to raise awareness of their pharmaceutical waste disposal service and drive improvements across the industry.
Peter Keyte, ruminant business unit manager at Ceva Animal Health said: "As an industry we should be doing all that we can to improve our environmentally friendly credentials.
“Ceva will continue to invest in innovative eco-friendly technology for livestock injectables and pioneer improvements to help ensure best practice throughout the industry.”
For further information, or to request a pharmaceutical waste disposal service support pack, contact your local Ceva account manager or call 01494 781510.
References
Strangvac has been in development for over 25 years and Dechra says it's the first and only intramuscular vaccine to help protect against strangles.
Strangvac contains recombinant proteins CCE, Eq85 and IdeE from Streptococcus equi and has DIVA (Differentiating Infected from Vaccinated Animals) capability.
The vaccine contains no live bacteria or bacterial DNA, so will not trigger positive culture or PCR tests.
In trials the new vaccine protected more than 94% of horses1.
Dechra says it reduces the clinical signs of strangles including a high temperature, coughing, inappetence, difficulty swallowing and changes in demeanour, while also reducing the number of lymph node abscesses.
Strangvac can be given to foals from five months of age and two injections should be given at a four-week interval.
Horses at high risk of Streptococcus equi infection, such as those in livery, should be revaccinated after two months.
Based on measured antibody titres, immunological memory was found in horses following repeated vaccination six months after primary vaccination.
Dr Andrew Waller, chief scientific officer at Intervacc AB, the company that developed the vaccine, said: “Strangvac is a ground-breaking new vaccine which, alongside good stable management and biosecurity procedures, can play a really important role in improving herd immunity and reducing the number of strangles cases in the equine population, thereby preventing major economic loss to the equestrian industry.”
https://www.dechra.co.uk/equine/vaccines
The step-by-step guide offers guidelines to help farmers improve their herd's mobility.
It highlights the importance of implementing a robust and ongoing treatment plan to improve cow comfort and reduce lameness in the short-term, which will lead to increased production and herd welfare in the longer-term.
The guide includes advice on reviewing a whole herd by an independent RoMS (Register of Mobility Scorers) accredited mobility scorer, seeking veterinary advice or contacting a mobility mentor (someone who has been trained to deliver the ADHB Healthy Feet Programme) if lesions are identified, treating within 48 hours of identification with a combination of trim, block, topical antimicrobial spray and non-steroidal anti-inflammatory (NSAID), as appropriate, and the importance of ongoing treatment, prevention and monitoring every fortnight.
The guide also includes tips for the successful use of NSAIDs, which include the importance of using a NSAID with a zero milk withhold.
There are four lameness management videos which were produced in collaboration with James Wilson BSc (Hons) PhD, a foot health consultant from Herd Health Consultancy and include contributions from Alex Burrows, professional foot trimmer and Chair of the National Association of Cattle Foot Trimmers (NACFT), Dave Bacon, a dairy farmer from Gleadthorpe Farm in Nottinghamshire, Shannon Trinder, assistant herdsperson at Gleadthorpe Farm and Harry Walby BVetMed MRCVS, veterinary surgeon and ruminant technical advisor at Ceva Animal Health.
They cover the benefits of regular mobility scoring, prioritising mobility and lameness prevention in heifers and maintaining lameness management success with practical and effective lameness treatment and prevention programmes.
www.wavegoodbyetopain.co.uk/pdf/step-by-step-guide.pdf.www.wavegoodbyetopain.co.uk/training-videos.html.
According to the company, the new Avacta Allergy+ offers:
Existing customers will be getting a launch pack this week, which comes with a box of Yorkshire teabags (as that's where Avacta heralds from) and a pack of chocolate biscuits so practice staff can take break whilst they peruse details of the new portfolio and accompanying support materials.
To encourage the reuse of the old Avacta submission boxes, the company is also running a competition where practices can win a £100 Amazon gift voucher if they come up with the most practical and imaginative reuse idea. Full details can be found at avactaanimalhealth.com/news.
For more information visit www.avactaanimalhealth.com.
The deal includes an option for the College to lease the building for up to two years to give it time to consider its options for the future, and how they may have changed as a result of the pandemic.
The decision to sell the property was made back in November 2018, when Council decided that the building was rapidly becoming unfit for purpose and the College needed more up-to-date and modern facilities with more room for a growing workforce. The College’s Estates Strategy Project Board was tasked with managing the process, chaired by former RCVS President Barry Johnson.
RCVS Treasurer Susan Dawson said: “Council recognised that this deal realised maximum value for the building, especially considering the impact the pandemic has had on property prices in Central London.
“It also provides a very valuable opportunity to reflect on the changing needs of the organisation and the professions and public it serves, and to consider the requirements and different working patterns of the College staff going forwards.
“It is likely that many staff members will wish to continue to work at home more than they did pre-Covid, so the need for pure desk-space may not be as great as we had planned for the 10-15 years ahead. However, the importance of in-person meetings for collaboration, creativity and the maintenance of good corporate culture is not to be underestimated, so our new requirements are likely to be different to that anticipated back in 2018.”
The College says it expects to welcome limited numbers of staff back to the office in June, to work in a socially distanced way, including virtual or partly-virtual meetings.
Changes to working patterns over the coming months will also help inform decisions around future remote working policies and the type and size of building that will best suit the future needs of the College and its workforce.
The new GPCert programme, led by course director Owen Davies MA VetMB MVetMed MANZCVS (Small Animal Medicine) DipACVIM (Oncology) (pictured right), consists of 12 modules covering key clinical subjects in veterinary oncology delivered over 14 months.
Each module consists of nine lessons, two case studies, course notes and weekly summary videos.
Lessons are supported by notes and videos, quizzes and a forum tutored by leading specialists.
Owen said: “Half of all canine cancers are treatable if caught early enough and new treatments are continuously being researched.
"The programme will guide delegates through the latest knowledge in state-of-the-art, compassionate cancer care for animals, helping them to provide safe and comprehensive diagnostics and treatments.”
For more information, visit: https://www.improveinternational.com/uk/course/oncology-online-learning/
Virbac says this is the only wet product to provide separate species-specific dog and cat convalescence diets tailored to the unique nutritional needs of both species.
In an internal study conduct by Virbac, 86% of dogs with digestive issues improved within a week of using the diet1
The new diets are high in protein and low in carbohydrate and they can be used alone or in combination with the company's dry diets (suggested 50/50 split).
Andrew Connolly, Marketing Director – UK & Ireland at Virbac said: “We’re thrilled with the overwhelmingly positive feedback we've received on our new Veterinary HPM Digestive Support wet diets.
“Practices and pet owners alike are commenting on the extraordinary palatability of the diets and their effectiveness, particularly with convalescing and inappetent pets”.
Companion Care Vets has reported a record calendar year in 2010, with 15 new surgeries opened taking the network up to 69.
Companion Care also welcomed 17 new joint venture partners, increasing the total number of partners to 87. The company expects to double the number of surgeries over the next 3 years following the announcement that it is to open standalone practices alongside the in-store Pets at Home surgeries.
According to the company, the opening of 15 new full service surgeries represents an investment of approximately £3 million during the year. More than £340,000 of that investment went on state-of-the-art digital x-ray imaging equipment - a feature of all new surgeries.
Managing director, Jane Balmain, said: "The in-store model has been hugely successful and we will continue to accelerate our growth plans for in-store surgeries as the Pets at Home store footprint expands.
"The launch of our new standalone division provides a solution for the vets and nurses who are looking for a partnership but whose preference is for a more traditional standalone style surgery. The level of interest since our announcement has been massive and we will be looking to capitalise on this in 2011 and beyond.
"Our vision is for Companion Care Vets to become a truly national leading veterinary group and with the record year in 2010 and our plans for 2011 and beyond, we are now well on the way and confident of achieving this."
The Veterinary Medicines Directorate (VMD) has granted MSD Animal Health a provisional UK marketing authorisation for Bovilis SBV, the first vaccine specifically targeting the Schmallenberg virus (SBV) in cattle and sheep.
SBV, which emerged in late 2011, is transmitted via insect vectors, mainly midges and causes transient clinical symptoms in adult cattle and sheep, such as fever, diarrhoea and reduced milk yield, as well as congenital malformation in newborn calves and lambs. As of March 31st 2013, 1753 cases of SBV had been confirmed throughout the UK. SBV has now been detected in every county in England and Wales.
Andras Bolcskei, Country Manager, MSD Animal Health UK said: "On behalf of Merck MSD, we would like to thank the VMD for its partnership and support to fast track the availability of Bovilis SBV to the market. There was a tremendous urgency for a SBV vaccine in the UK especially given the marked increase in confirmed cases over the past year and the increasing importance to help control this devastating disease."
MSD says that studies it conducted in support of the provisional marketing authorisation showed that all animals responded with formation of virus neutralizing antibodies. During the studies, reduced viraemia against SBV was observed in sheep vaccinated once and prevention of viraemia was observed in cattle vaccinated twice, whereas all animals in the control groups developed infection and became viraemic. In studies to date, Bovilis SBV has been shown to be efficacious in cattle and sheep.
The vaccine is based on wild-type SBV that has been inactivated and contains an adjuvant that stimulates the immune response.
The vaccine will be available in 20ml and 100ml vials. Bovilis SBV is indicated for the active immunisation of cattle to prevent viraemia against SBV and for the active immunisation of sheep to reduce viraemia against SBV.
MSD says it is working diligently to expedite stocks to the UK, and expects Bovilis SBV to arrive in the UK in the coming weeks.
The advert appeared in three separate issues of Veterinary Times (15, 22 and 29 September 2014), on the rear back cover of the 2014 BEVA Congress proceedings, and on the inside back cover of the 2014 Congress Planner. It contained the phrase “Neuraminidase antibodies provided a degree of protection in the case of HA strain/vaccine mismatch”, when viewed against the context of the advertisement headed ‘Why have part when you can have it all?”.
The Committee’s view was that the item in the context of the advertisement was intended to mean, and did convey, the meaning that the inclusion of NA antigens in an equine vaccine gave that vaccine a clinical advantage over vaccines which did not. This claim was not substantiated. Accordingly, the Committee found the phrase in breach of Code of Practice Clauses 4.1(iii) misleading, 4.1(vi) contained an exaggerated claim, 4.1(vii) implied it had a special merit which was not substantiated, 4.2(i) was not accurate and 4.2(ii) was not based upon an up-to-date evaluation of all the evidence.
Full details of the Committee’s rulings can be found on the NOAH website at www.noah.co.uk/code. The full report of this particular case will be available shortly.
Drawing attention to the symptoms of allergic skin disease that owners should look out for during the warmer months, the leaflet, poster and notice board materials discuss some of the substances that dogs can be allergic to, how to manage skin allergies and what to look for in an itch prevention plan.
The materials have been produced to support Apoquel, the oral therapy for the treatment of canine pruritus associated with allergic dermatitis and the clinical manifestations of atopic dermatitis. They feature two dogs – Eric and Daisy – whose lives have been changed by the product.
For more information, contact your Zoetis account manager.
It was alleged that in September 2015, she had acted inappropriately by striking a Shih Tzu/Toy Poodle cross puppy called Arnie on his head.
The hearing commenced on Tuesday 3 January 2017 with evidence being given by the owner of the animal ("TC"). However, the corroborating witness, who was also the complainant in the case, failed to attend the hearing to give evidence.
Efforts were made by the College to contact the complainant and remind her that she had been summoned to appear before the Committee – however, she still chose not to attend the hearing to give evidence. In response to her non-appearance the Committee decided that her written evidence was inadmissible as there would be no opportunity to cross-examine her about the discrepancies between her account and that of TC.
Miss Faulkner’s counsel then made an application to the Committee that the College had failed to sufficiently prove its case to the requisite standard such that it would not be necessary for her to adduce any evidence in her defence. The Committee granted this on the grounds that there were clear inconsistencies in the evidence given by TC at different stages of the investigation and during the hearing itself.
Chitra Karve, chairing the Committee and speaking on its behalf, said: "The Committee was unable to conclude that TC was a reliable witness. Given TC’s centrality to the case the Committee is unable to be satisfied so that it is sure that her account of events as outlined in her oral evidence is accurate. Accordingly, the Committee is not satisfied that the College has proved to the requisite standard that the respondent did in fact strike Arnie to the head as alleged.
"Accordingly, the Committee accepts the submission made by the respondent that the College has not adduced sufficient evidence upon which it can find the facts alleged in the charge to be proved. Therefore, it is not necessary for the Committee to consider this matter any further. There is no case for the respondent to answer."
The broached bottle must be kept refrigerated between 20C and 80C until the next use.
Virbac says that whilst this may not seem a huge change, it significantly increases the cost-effectiveness and convenience to farmers.
The SPC changes mean that
Bovigen Scour is available in 5 and 30 dose bottles.
Clare (pictured) who is currently the General Dental Council’s Interim Executive Director for Legal and Governance, will be joining the RCVS as its most senior legal officer at the end of March 2025.
A qualified solicitor, Clare started her practice as a Solicitor Advocate in criminal law, before undertaking roles in regulatory bodies in the healthcare and financial sector.
She joined the General Dental Council in March 2023 and has been in her current role there since March last year.
When she joins the College, Clare will have a dual role.
As Registrar she will be responsible for keeping, maintaining and publishing Registers of veterinary surgeons and veterinary nurses, including oversight of the various mechanisms via which veterinary professionals can join the Register, what they need to do to stay on the Registers, how they may leave or be removed and registration appeals.
As Director of Legal Services, she'll provide leadership and guidance on legal matters within the organisation, including guiding RCVS Council through the development of oral and written legal advice, as well as sitting on committees and working groups in order to ensure the College’s activity is within its legal remit and represents best practice.
RCVS Chief Executive Officer Lizzie Lockett said: “I am sure the RCVS, the professions and the public will benefit from her very relevant experience from senior roles within the General Dental Council, Nursing and Midwifery Council, and Financial Conduct Authority, as well as her private sector legal experience.
“She joins the College at a time of change, with our continued push for new veterinary legislation, the ongoing Competition and Markets Authority investigation of the sector, and a new strategic plan for the College due to be approved this spring.
“The Registrar is the senior legal figure within the organisation, and I am looking forward to Clare contributing her legal expertise on these significant areas of work.
"She joins our very capable legal team, who I am sure will benefit from her leadership, as she will benefit from their sector expertise.”
Clare said: “I am delighted to join the Royal College of Veterinary Surgeons to contribute to the valuable work of safeguarding the interests of the public and animals by supporting veterinary professionals to provide the highest standards of care.”
VetSurgeon.org extends a warm welcome to Clare and wishes her all the very best in her new position.
One small but nevertheless important point is that perhaps a better aim would be to support veterinary professionals in providing just a 'high' standard of care, rather than the 'highest' standards.
It's this constant striving for the 'highest' standards from both a regulatory and clinical perspective that is driving up the cost of veterinary care and making it unaffordable.
Mike, an RCVS Queen’s Medal winner, will be in conversation with Catheryn Partington BVSc CertAVP(VC) MSc MRCVS, Jose Matos DVM DipECVIM (Cardiology) MRCVS European and RCVS Recognised Specialist in Small Animal Cardiology (canine and feline cardiology) and Paul Freeman MA, VetMB, Cert SAO, Dip ECVN, MRCVS (European and RCVS Specialist in Veterinary Neurology) (canine and feline neurology).
During the event, they will be explaining how Improve's new Academy Series can help vet professionals meet their annual CPD targets, learn through self-assessment and reflective study, and bring them to the forefront of medicine in several specialist areas.
Heber Alves, CEO of Improve International, said: “Here at Improve International, we are proud to be providing CPD training alongside the historic and prestigious University of Cambridge for our first Academy Series.
"We are excited to be working with many of its pioneering specialists at the Department of Veterinary Medicine and, as a former vet myself, I look forward to hearing how my fellow veterinarians handled the most difficult challenges of their careers.”
www.improveinternational.com
Each candidate will produce a written reply to two questions of their choice, which will be included on their candidate profile webpage ahead of the start of the election.
The 14 candidates who are standing in this year’s election for the three available elected places on RCVS Council are:
The biographies and election statements for each candidate are available to read at www.rcvs.org.uk/vetvote24.
The three candidates with the most votes will join Council for their four-year terms at the College’s AGM in July.
The College says it will only accept one question per person and questions must be decent.
Offensive, defamatory and inaccurate questions will not be passed on to candidates.
You can email your question to: vetvote24@rcvs.org.uk
Virbac highlights research which shows that 90% of all dogs over one year are affected by dental issues, including plaque, tartar, gingivitis and halitosis1, but small breed dogs are 5 times more likely to have dental issues than large breeds2.
The new formulation of Veterinary HPM Small & Toy range contains Ascophyllum Nodosum, which Virbac says has been scientifically proven activity on four aspects of oral and dental health: calculus index, volatile sulphur compound concentration, plaque index and gingival bleeding index3.
Virbac points to research which shows that after being absorbed in the small intestine and then secreted into the oral cavity via saliva, Ascophyllum Nodosum inhibits some pathways involved in plaque or calculus development4.
Nutrition-wise, Virbac says the new diet offers 33% less carbohydrate and 34% more protein, on average, compared to other brands sold in veterinary practices5.
90% of the protein included in the diets is also from animal protein.
The updated range also features 2 new kibble sizes (10.5mm & 7.5mm), for smaller mouths.
A new study published in Equine Veterinary Journal's (EVJ) in partnership with the American Association of Equine Practitioners, has shown that a wireless, inertial sensor-based system can effectively measure a horse's response to a flexion test.
The authors say that opinions on the value of flexion tests in assessing equine lameness have been divided for many years, but their research should turn what has always been regarded as a subjective process into a wholly objective one.
Flexion tests are used routinely in horses with subtle or imperceptible lameness, to exacerbate the problem and make it apparent to the observer. The test involves applying a short period of pressure to the joints of the limb before re-examination, and evaluating any change in gait. However, flexion tests rely on the ability of the observer to identify and interpret changes in the horse's gait and in that respect these tests are subjective and not necessarily consistent between observers.
The research study was conducted by orthopaedic surgeons based at the University of Glasgow's School of Veterinary Medicine1. A total of 17 healthy adult horses, all in work, were fitted with sensors before being trotted in a straight line. The sensors measured vertical pelvic movement asymmetry for both right and left hind limb strides and the average difference in maximum and minimum pelvic height between right and left hind limb strides. A hind limb was randomly selected for 60 seconds of proximal flexion, after which the horse was trotted for a minimum of 10 strides. Response to the flexion was blindly assessed as negative or positive by an experienced observer.
John Marshall, lecturer in equine surgery at the University of Glasgow, who led the study, said: "A positive response to flexion resulted in significant changes to objective measurements of pelvic symmetry, supporting the use of inertial sensor systems to objectively assess response to flexion tests."
Professor Jim Moore, North American Editor of the EVJ, said: "The introduction of an objective approach to documenting lameness examination will not only help vets and trainers to investigate equine lameness more accurately. It will also serve as an unbiased method of communicating lameness examination findings among vets, trainers, farriers and other professionals."
The next phase of research will be to establish cut-off values for objective assessment of other equine lameness diagnostic procedures, such as nerve blocks.
Reference
Zoetis has announced the availability in the UK and Ireland of Poulvac IBQX, the first specific vaccine against the QX strain of the infectious bronchitis virus.
For the past two years the vaccine has only been available with a special import certificate from the Veterinary Medicines Directorate for use on flocks where the QX virus has been isolated.
According to the company, this variant IB strain has been an increasing problem in European countries over the last 10 years and was first seen in the UK in South-East England in 2007. Since then QX has been isolated from a number of commercial layer and broiler flocks, leading to inferior performance and increased mortality.
James Porritt, Zoetis Poultry Manager for the UK and Ireland said: "Poulvac IB QX adds another protection dimension to our extensive IB vaccine portfolio. The Zoetis IB portfolio offers the widest choice and with Poulvac IBMM + ARK we have the UK's only bivalent live vaccine licensed for day-old use providing a Massachusetts strain and protection against 793/B/91 variant type strains lasting for six weeks post vaccination. Other IB Vaccines include Poulvac H120 and the UK's only other bivalent live vaccine Poulvac IB Primer."
Poulvac IB QX vaccine is based on a live attenuated virus and is administered as a coarse spray to broilers from day-old and to layer pullets or broiler breeders from seven days of age. Protection has been demonstrated by challenge study to last for 63 days after vaccination.
Zoetis says the vaccine is often used on the farm, but can be administered to chicks at the hatchery if adequate controls are in place to avoid spread to other chicks that will be moved to non-QX exposed flocks.
Dr Stuart Andrews, Poultry Veterinary Manager for Zoetis said: "In countering the QX virus strain some existing vaccines have been used to provide a degree of cross-protection. However, it is important to appreciate that Poulvac IB QX is a vaccine homologous to any IB QX field strain and so will provide even better protection.
"Furthermore, our in-house PCR and DNA sequencing service allows us to monitor carefully the field situation to ascertain which IB strains are currently causing field outbreaks and enable us to recommend adaptations to particular vaccination programmes.
"The full approval for the Poulvac vaccine will make it easier and more effective to tackle specific QX infections without having to apply for an import certificate."
In short, it’s a system which gives clients a breakdown of the options you have recommended, with an explanation of the procedure or treatment, potentially the pros and cons, and the price.
When time permits, this allows the client to consider their options at home, on their own, with the information in front of them, taking away the pressure that sometimes comes with having to make these decisions in front of a veterinary professional.
The system works as a standalone web-based service at present, but integrations with VetIT and Lupa are in development.
Practices can configure the software with their own information about treatment and procedures, but VetConsent has also teamed up with Visiocare and Vetlexicon to provide graphically rich material to help the client understand even better.
The service costs £40 per vet per month.
Chief Veterinary Officer, Nick Lloyd MRCVS said: “We’re confident that the time-savings alone will more than cover the cost of the service, but even more importantly, it improves the service you offer clients and ensures that you’ve covered all the bases in getting informed consent.”
https://vetconsent.com
The Royal College of Veterinary Surgeons has set up a new Veterinary Legislation Group to consider proposals for changes in veterinary regulation, in the light of the Environment, Food and Rural Affairs Committee's inquiry into the current Veterinary Surgeons Act, and the Government's response to the EFRA Committee's report.
The new group, which will be chaired by RCVS Council Member and Dean of Glasgow Veterinary School, Professor Stuart Reid, will be tasked with taking a fresh look at changes that need to be made to the current legislative framework, and how these might be accomplished. It will not restrict itself to looking at a replacement for the Veterinary Surgeons Act, but will consider other ways that changes can be made in the short- and long-term.
The Group will meet in September, and comprise RCVS Council members and non-members - both lay people and veterinary surgeons. Once the RCVS position has been clarified, further discussion will follow with DEFRA, the BVA and the profession.
Responding to the Government's response to the EFRA Committee report, RCVS President Jill Nute said: "We welcome the fact that DEFRA is willing to consider any detailed proposals that might come forward from the profession, although we accept that DEFRA itself does not have time or resources to be proactive at this stage.
"We are also pleased that Government acknowledges that the veterinary nursing profession has come of age and that the time is right for the regulation of veterinary nurses to be taken forward, although again it is disappointing that DEFRA does not have the resources to progress this at present.
"Finally, we welcome the suggestion that the Presidents of the BVA and the RCVS meet with the Chief Veterinary Officer to discuss plans and to what extent DEFRA can help us - accepting the fact that DEFRA, like the RCVS, feels that a piecemeal approach may not be the most effective," she concluded.